CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION

CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION

Aim. To assess clinical and predictive value of serum IL-18 in ST elevation myocardial infarction.Material and methods. Totally, 132 patients included, hospitalized to Kemerovo cardiovascular dispensary due to STEMI with <24 hours pain onset. Assessment of IL-18 concentration (pg/ml) was done...

Full description

Bibliographic Details
Main Authors:	M. V. Zykov, V. V. Kashtalap, I. S. Bykova, O. N. Khryachkova, V. V. Kalaeva, K. S. Shafranskaya, V. N. Karetnikova, O. L. Barbarash
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-11-01
Series:	Российский кардиологический журнал
Subjects:	myocardial infarction interleukine-18 multifocal atherosclerosis prognosis
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/458

Similar Items

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

ROLE OF THE SERUM NGAL FOR ASSESSMENT OF HOSPITAL PROGNOSIS IN MEN WITH ST ELEVATION MYOCARDIAL INFARCTION
by: V. N. Karetnikova, et al.
Published: (2015-06-01)

The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
by: V N Karetnikova, et al.
Published: (2016-06-01)

COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS
by: M. V. Zykov, et al.
Published: (2012-02-01)

Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01)

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE
by: K. S. Shafranskaya, et al.
Published: (2015-03-01)

THE ROLE OF MULTIFOCAL ATHEROSCLEROSIS IN DEVELOPMENT OF UNFAVORABLE CARDIOVASCULAR OUTCOMES IN PATIENTS AFTER CORONARY BYPASS GRAFTING
by: L. S. Barbarash, et al.
Published: (2016-02-01)

PROGNOSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION, IN REGARD TO THE PRESENCE OF TYPE 2 DIABETES MELLITUS AND SELECTED TREATMENT STRATEGY IN THE ACUTE PERIOD
by: Yu. A. Belen’kova, et al.
Published: (2012-10-01)

Pro-inflammatory cytokines and depression in myocardial infarction
by: O. L. Barbarash, et al.
Published: (2011-04-01)

Renal function estimation formulas in predicting long-term cardiovascular outcomes in patients with myocardial infarction concurrent with diabetes mellitus
by: V N Karetnikova, et al.
Published: (2016-04-01)

Interleukin-18 Promoter Gene Polymorphisms are not Associated with Myocardial Infarction in Type 2 Diabetes in Slovenia
by: Kariž S, et al.
Published: (2011-01-01)

Comorbidity in acute heart failure complicating myocardial infarction
by: M. V. Zykov, et al.
Published: (2020-08-01)

THE STUDY OF RS1800629 (G-308А) POLYMORPHISM OF THE TNF GENE IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ELEVATED ST SEGMENT
by: M. V. Zykov, et al.
Published: (2014-10-01)

Interleukin 18 levels in patients with stable coronary artery disease is associated with IL18RAP and IL18R1 gene polymorphism and the risk of myocardial infarction
by: A. V. Ponasenko, et al.
Published: (2020-11-01)

Renal dysfunction in patients with myocardial infarction concurrent with type 2 diabetes mellitus
by: M V Evseeva, et al.
Published: (2015-01-01)

THE INFLUENCE OF MULTIFOCAL ATHEROSCLEROSIS ON LONG-TERM OUTCOMES AFTER ENDOVASCULAR REVASCULARIZATION IN MYOCARDIAL INFARCTION
by: R. S. Tarasov
Published: (2015-02-01)

CLINICAL AND PROGNOSTIC VALUE OF INTERLEUKIN-12 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2014-07-01)

Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction
by: M. V. Zykov, et al.
Published: (2021-03-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

RESULTS OF ENDOVASCULAR REVASCULARIZATION IN ELDERLY PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION IN MULTIVESSEL DISEASE
by: A. M. Kochergina, et al.
Published: (2016-03-01)

Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
by: O V Gruzdeva, et al.
Published: (2016-04-01)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure
by: Stefano Toldo, PhD, et al.
Published: (2017-08-01)

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
by: Amundsen, B.H, et al.
Published: (2022)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

SPECIAL FEATURES OF REHABILITATION AND OUTCOME PREDICTION IN MYOCARDIAL INFARCTION COMPLICATED BY ARRHYTHMIAS
by: N. I. Tarasov, et al.
Published: (2001-06-01)

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
by: O L Barbarash, et al.
Published: (2019-12-01)

Interleukin-6 gene −572 G > C polymorphism and myocardial infarction risk
by: Ding He-guo, et al.
Published: (2020-05-01)

Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries
by: O. L. Barbarash, et al.
Published: (2020-05-01)

A patient with сoronary artery disease and multifocal atherosclerosis. How to optimize the prognosis?
by: O. L. Barbarash, et al.
Published: (2018-09-01)

A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting
by: Tejas P. Singh, et al.
Published: (2018-07-01)

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
by: Marc Jonathan George, MB ChB, PhD, et al.
Published: (2021-05-01)

Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?
by: M. V. Zykov, et al.
Published: (2021-09-01)

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2014-03-01)

Place of pharmaco-invasive approach for revascularization in acute myocardial infarction: Experience of Kuzbass
by: Tavlueva E.V., et al.
Published: (2015-09-01)

CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-06-01)

Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo)
by: D. Yu. Sedykh, et al.
Published: (2020-01-01)

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
by: O. L. Barbarash, et al.
Published: (2020-09-01)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
by: Gruzdeva O, et al.
Published: (2017-12-01)

PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES
by: R. M. Magdeev, et al.
Published: (2016-01-01)

New-onset chronic obstructive pulmonary disease and its clinical significance in patients with ST-segment elevation myocardial infarction
by: O M Polikutina, et al.
Published: (2014-03-01)

Cannot write session to /tmp/vufind_sessions/sess_m1bd6g8pb1s92acplu1267kclu